Company Filing History:
1 out of 462 
1 out of 7 Years Active: 2022
Title: Paul Gregorevic: Innovator in Gene Delivery for Muscle Health
Introduction
Paul Gregorevic is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of gene therapy, particularly in the context of muscle health. His innovative work focuses on addressing muscle wasting conditions, which can be critical for patients suffering from various diseases.
Latest Patents
Gregorevic holds a patent for the delivery of the SMAD7 gene into muscle cells. This patent describes vectors, such as adeno-associated virus (AAV) vectors, and recombinant AAV expressing Smad7. The disclosed AAV vectors and rAAV can be utilized for therapeutic applications aimed at treating and ameliorating muscle wasting, particularly in cases associated with cancer cachexia.
Career Highlights
Throughout his career, Paul Gregorevic has worked with esteemed institutions, including Washington State University and the Baker Heart and Diabetes Institute. His research has focused on developing innovative solutions to combat muscle wasting, showcasing his dedication to improving patient outcomes.
Collaborations
Gregorevic has collaborated with Buel Dantese Rodgers, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Paul Gregorevic's contributions to gene delivery and muscle health represent a significant advancement in therapeutic applications. His work continues to inspire future innovations in the field of medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.